Anti-Human LAG3 Recombinant Antibody_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human LAG3 Recombinant Antibody

Anti-Human LAG3 Recombinant Antibody

产品编号

YR1554

别名

科研级 Ieramilimab (埃拉利单抗 ), Anti-LAG3 Recombinant Antibody, Research Grade Ieramilimab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Alias	科研级 Ieramilimab (埃拉利单抗 ), Anti-LAG3 Recombinant Antibody, Research Grade Ieramilimab
Catalog Number	YR1554
Molecular Name	Ieramilimab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG4 Kappa
Formulation	PBS, pH7.5
Background	Ieramilimab (development code LAG525) is a monoclonal antibody being developed by Novartis for the treatment of cancer. The antibody targets the immune checkpoint LAG-3, which is expressed on T cells and tends to down-regulate an immune response. In a June 2015 presentation Novartis management indicated that 'dosing is imminent' for the first clinical trials of LAG525.
CAS Number	2137049-37-5
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	LAG3[Homo sapiens]

推荐产品

400-621-6806
614353794
周一至周五 9:00-18:00
0